1. Pryor, J.P.: Introduction to the Management of Superficial Bladder Tumours; in: Bladder Cancer R.T.D. Oliver, W.F. Hendry, H.J.G. Bloom (Hrsg.), Butterworths, London 1981.
2. Pryor, J.P.: Factors influencing the survival of patients with transitional cell tumours of the urinary bladder. British Journal of Urology, 45: 586–593 (1973).
3. Jacobi, H.H., Kurth, K.H., Klippel, K.F., Hohenfellner, R.: On the biological behaviour of T1-transitional cell tumours of the urinary bladder and initial results of the prophylactic use of topical Adriamycin under controlled and randomized conditions; in: WHO Collaborating Centre for Research and Treatment of Urinary Bladder Cancer (Hrsg.). Diagnostics and Treatment of Superficial Urinary Bladder Tumors. Montedison Lakemedal AB, Stockholm 83–94 (1979).
4. Lunglmayr, G., Czech, K.: Absorption studies on intraluminal thio-tepa for topical cytostatic treatment of low-stage bladder tumors. Journal of Urology, 106: 72–74 (1971).
5. Veenema, R.J., Dean, A.L., Jr. Roberts, M., Fingerhut, B., Chowhury, B.K. und Tarassoly, H.: Bladder carcinoma treated by direct instillation of Thiotepa. Journal of Urology, 88: 60–63 (1962).